Halozyme Therapeutics Stock Price Transform Average Price

HALO Stock  USD 76.92  2.59  3.26%   
Halozyme Therapeutics price transform tool provides the execution environment for running the Average Price transformation and other technical functions against Halozyme Therapeutics. Halozyme Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of price transform indicators. As with most other technical indicators, the Average Price transformation function is designed to identify and follow existing trends. Halozyme Therapeutics price transformation methods enable investors to generate trading signals using basic price transformation functions such as typical price movement.

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Halozyme Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

Halozyme Therapeutics Technical Analysis Modules

Most technical analysis of Halozyme Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Halozyme from various momentum indicators to cycle indicators. When you analyze Halozyme charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Halozyme Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Halozyme Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Halozyme Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Halozyme Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Halozyme Therapeutics's daily price indicators and compare them against related drivers, such as price transform and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Halozyme Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Halozyme Therapeutics, we also check how macroeconomic factors affect Halozyme Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 2025 2026 (projected)
Payables Turnover16.2815.5514.014.7
Days Of Inventory On Hand242.12324.8373.52574.15
Hype
Prediction
LowEstimatedHigh
74.5476.6378.72
Details
Intrinsic
Valuation
LowRealHigh
76.5978.6880.77
Details
8 Analysts
Consensus
LowTargetHigh
70.9878.0086.58
Details
Earnings
Estimates (0)
LowProjected EPSHigh
2.012.042.14
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Fundamentals Comparison Now

   

Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested over 90 shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested over 90 shares
ESG Investing Idea
ESG Investing
Sold few shares
Millennials Best Idea
Millennials Best
Invested over 90 shares
When determining whether Halozyme Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Halozyme Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Halozyme Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Halozyme Therapeutics Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Halozyme Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Halozyme Stock, please use our How to Invest in Halozyme Therapeutics guide.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Will Biotechnology sector continue expanding? Could Halozyme diversify its offerings? Factors like these will boost the valuation of Halozyme Therapeutics. Market participants price Halozyme higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Halozyme Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
0.362
Earnings Share
4.7
Revenue Per Share
10.185
Quarterly Revenue Growth
0.221
Return On Assets
0.2124
The market value of Halozyme Therapeutics is measured differently than its book value, which is the value of Halozyme that is recorded on the company's balance sheet. Investors also form their own opinion of Halozyme Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Halozyme Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Halozyme Therapeutics' market value can be influenced by many factors that don't directly affect Halozyme Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Halozyme Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Halozyme Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Halozyme Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.